Skip to Main Content

Amid controversy over the use of patient coupons, Pfizer has agreed to refund $290,000 to settle charges of misleading roughly 5,000 people in Colorado, Kansas, Vermont, and Arizona who spent much more than expected when they used coupons supplied by the drug maker. The company will also pay a total of $120,000 to the states to cover legal costs, among other things.

This is only the latest instance in which Pfizer has been cited over such allegations. Three years ago, the company paid $975,000 to settle charges of misleading consumers in Oregon and, in 2018, it reached a $700,000 settlement with New York State. In each episode, consumers were told they would “pay no more than” a small amount of money — typically, from $15 to $25 — for certain drugs, but were actually required to pay more due to limits on total savings that were not prominently disclosed.


The drugs cited in the agreement were Estring, which treats moderate to severe symptoms related to menopause; Quillivant, which treats attention deficit hyperactivity disorder; and Flecto0r Patch, which is used to treat acute pain due to minor strains, sprains, and bruises, according to the settlement. The infractions occurred from 2014 to 2018.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Create a display name to comment

This name will appear with your comment

There was an error saving your display name. Please check and try again.